T Lymphocyte Activation: The Two-Signal Model and Signaling Pathways

A T cell is dangerous when it fires. A cytotoxic T cell kills; a helper T cell unleashes a cascade of inflammation. So the immune system builds in a safety rule: a T cell must receive two separate signals before it will fully activate.

The first signal proves the T cell has found its specific target. The second signal proves that the target is genuinely dangerous. Only when both arrive does the T cell commit. This two-signal requirement is the heart of T-cell activation, and it explains both how the immune system avoids attacking the wrong things and how drugs like cyclosporine can switch the whole process off to protect a transplant.

This article covers how a mature, naive T cell in the periphery becomes activated: the two signals, the third signal that shapes the outcome, and the intracellular cascade that carries the message from the cell surface to the nucleus.

What activated T cells then do, the subsets they become and how they kill or coordinate, is covered in the article on cell-mediated immunity.

T-cell activation at a glance

Before the details, here is the whole sequence in order:

1. Antigen recognition: an antigen-presenting cell displays a peptide on an MHC molecule, and a T cell whose receptor matches it binds.

2. Two signals delivered: the TCR engages the peptide-MHC (signal 1), and co-stimulation confirms danger (signal 2). Both are required.

3. Signal travels inward: a relay of enzymes carries the message from the surface receptor to the nucleus, switching on T-cell genes.

4. Clonal expansion: the activated T cell multiplies rapidly into a large population all specific for the same antigen.

5. Migration and effector action: the cells travel to the site of infection and do their work.

6. Contraction and memory: after the threat clears, most effector cells die, but some persist as memory cells for a faster response next time.

The rest of this article elaborates on the parts that carry the most weight: the two-signal model, how CD8 cells get help, and how the signal travels inward.

The two-signal model

A naive T cell will not activate on antigen recognition alone. It requires two signals delivered at the same time by the same antigen-presenting cell.

Signal 1 is antigen recognition. The T-cell receptor binds a peptide displayed on an MHC molecule. For a CD4 T cell this is a peptide on MHC class II; for a CD8 T cell it is a peptide on MHC class I. The pairing follows the rule of eight: CD4 goes with MHC class II (4 × 2 = 8) and CD8 goes with MHC class I (8 × 1 = 8). This is covered in more detail in the article on MHC molecules.

This signal provides specificity: it confirms the T cell has found the exact antigen it was built to recognize. But signal 1 alone is not enough. A T cell that receives signal 1 without signal 2 does not activate; instead it becomes unresponsive (anergic) or dies. This is a deliberate safety mechanism.

Signal 2 is co-stimulation. A separate pair of molecules must also engage: B7 (CD80/CD86) on the antigen-presenting cell binds CD28 on the T cell. This signal confirms that the antigen was picked up in a genuinely dangerous context, because B7 is only displayed strongly by antigen-presenting cells that have themselves been alarmed by infection. Signal 2 is the "danger confirmed" check.Only when signal 1 and signal 2 arrive together does the T cell fully activate, proliferate, and differentiate.

There is also a signal 3. After activation, cytokines from the innate immune system tell the T cell what kind of effector cell to become. This third signal does not switch activation on or off; it directs the outcome, steering a CD4 T cell toward Th1, Th2, Th17, or another fate depending on the cytokines present. The details of those fates belong to cell-mediated immunity.

The logic in one line: signal 1 asks "is this my antigen?", signal 2 asks "is it really dangerous?", and signal 3 asks "what kind of response is needed?"

How a CD8 T cell gets help: licensing the dendritic cell

There is a problem hidden in the two-signal model. A CD8 cytotoxic T cell needs co-stimulation (signal 2) to activate, but a resting dendritic cell may not display enough B7 to provide it. So how does a CD8 cell get fully activated? The answer is that a CD4 helper T cell prepares the dendritic cell first, in a step called licensing.

It works in a sequence:

A CD4 helper T cell recognizes antigen on the dendritic cell and, once activated, expresses a molecule called CD40L. CD40L binds CD40 on the dendritic cell. This engagement licenses the dendritic cell: it now expresses more co-stimulatory B7 molecules and secretes cytokines. The licensed dendritic cell is now a much better antigen-presenting cell, and it can deliver full signal 2 to a CD8 T cell, which then activates and becomes a cytotoxic killer.

The practical meaning is that CD4 help is often required for a strong CD8 response, but indirectly: the CD4 cell does not talk to the CD8 cell directly. It upgrades the dendritic cell in the middle, which then activates the CD8 cell. This is why the loss of CD4 T cells, as in advanced HIV infection, weakens not only antibody responses but cytotoxic T-cell responses as well.

The CD40L-CD40 interaction here is the same one that lets helper T cells drive B cells in humoral immunity. The same handshake does two jobs: it licenses dendritic cells to activate CD8 cells, and it helps B cells make high-quality antibody.

From the surface to the nucleus: how the signal travels

The two signals arrive at the cell surface, but the genes that activate the T cell are in the nucleus. The intracellular cascade is how the message travels between them, and it is easier to follow as a relay than to memorize as a list.

The relay starts with a kinase called Lck, which sits under the co-receptor (CD4 or CD8). When the TCR engages peptide-MHC, Lck phosphorylates tyrosine motifs called ITAMs on the CD3 and zeta chains beside the receptor. These phosphorylated motifs recruit and activate the next relay protein, ZAP-70. Active ZAP-70 then passes the signal through a few branching pathways to three transcription factors: NFAT, AP-1, and NF-κB. These enter the nucleus and switch on the genes for cytokines, cytokine receptors, and cell-division proteins that drive the T cell into action.

One branch is worth knowing by name because of its clinical importance. The calcium pathway activates an enzyme called calcineurin, which is needed to switch on NFAT. The immunosuppressive drugs cyclosporine and tacrolimus work by blocking calcineurin. Without it, NFAT stays off, the T cell cannot make its key cytokines, and activation fails. This is why these drugs are central to preventing organ transplant rejection.

Co-stimulation through CD28 (signal 2) amplifies and sustains these signals, which is why signal 1 alone is not enough to fully activate the cell.

Clonal expansion and memory

Once fully activated, the T cell multiplies rapidly into a large population, all specific for the same antigen. The scale is striking. Before infection, the T cells specific for any one antigen are rare, on the order of 1 in 100,000 or fewer of all T cells. After activation, this population expands enormously, and CD8 T cells expand even more than CD4 T cells, so at the peak of a strong response the antigen-specific CD8 cells can make up a large fraction of all CD8 T cells. These numbers are approximate and vary with the infection, but they capture the point: activation turns a handful of specific cells into an army.

After the pathogen is cleared, most effector T cells die by apoptosis, and the population contracts. A small subset survives as memory T cells, which persist for years and respond faster and more strongly if the same antigen returns.

How to remember

Two signals, then go: "My antigen, and it's dangerous." Signal 1 (TCR-MHC) confirms the specific antigen. Signal 2 (B7-CD28) confirms danger. Signal 1 alone causes anergy, not activation. This is the single most important idea on the page.

Signal 3 shapes, it does not switch. The third signal (innate cytokines) decides what kind of effector cell forms (Th1/Th2/Th17), but it does not turn activation on or off.

The signaling relay: "Lck lights ZAP, ZAP splits three ways." Lck phosphorylates the ITAMs and activates ZAP-70; ZAP-70 branches the signal into three pathways ending in NFAT, AP-1, and NF-kB.

Cyclosporine blocks calcineurin. The calcium-NFAT pathway runs through calcineurin, and cyclosporine (and tacrolimus) block it. That is why these drugs stop T-cell activation and prevent transplant rejection. This is the clinical anchor: a drug that switches off signal 1's downstream pathway.

Licensing: CD4 upgrades the DC, the DC arms the CD8. A CD4 helper does not activate the CD8 cell directly. It licenses the dendritic cell through CD40L-CD40, and the licensed dendritic cell then activates the CD8 cell. This is why losing CD4 cells (as in HIV) also cripples cytotoxic responses.

From rare to army. Before infection, cells for one antigen are about 1 in 100,000. Activation expands them enormously, CD8 more than CD4. A handful becomes an army.

Key exam facts in one table

Where students get confused

"Antigen recognition alone activates a T cell." No. This is the central rule. A T cell needs two signals: TCR-MHC (signal 1) and co-stimulation (signal 2). Signal 1 by itself causes anergy or death, which is a deliberate safety mechanism against attacking self.

"Co-stimulation provides the specificity." No, it is the reverse. Signal 1 (TCR-MHC) provides specificity, confirming the right antigen. Signal 2 (B7-CD28) provides context, confirming danger. They answer different questions.

"Signal 3 turns activation on." No. Signal 3 (innate cytokines) shapes what kind of effector cell forms; it does not switch activation on or off. The on/off decision is made by signals 1 and 2.

"Cyclosporine kills T cells." Not exactly. Cyclosporine blocks calcineurin, which blocks the NFAT pathway, so the T cell cannot be activated. It suppresses activation rather than killing the cell, which is why it works as an anti-rejection drug.

"T-cell activation is the same as what T cells do." No, and this is the boundary of this article. Activation is how a resting T cell is switched on. What activated T cells then do, killing, helping, forming subsets, is cell-mediated immunity, covered separately.

"A helper T cell activates a killer T cell directly." Usually not. The CD4 helper licenses the dendritic cell through CD40L-CD40, and the licensed dendritic cell then activates the CD8 killer. The help is delivered through the dendritic cell in the middle, not cell-to-cell.

"CD40L only matters for B cells." No. The same CD40L-CD40 handshake does two jobs: it licenses dendritic cells to activate CD8 T cells, and it helps B cells make high-affinity, class-switched antibody. One molecule, two critical roles.

References

1. Abbas AK, Lichtman AH, Pillai S. Cellular and Molecular Immunology. 10th ed. Elsevier; 2022.
2. Punt J, Stranford SA, Jones PP, Owen JA. Kuby Immunology. 8th ed. W.H. Freeman; 2019.
3. Gaud G, Lesourne R, Love PE. Regulatory mechanisms in T cell receptor signalling. Nat Rev Immunol. 2018;18(8):485–497. https://doi.org/10.1038/s41577-018-0020-8